Nevin I.
- Country
- Bulgaria
- Department
- Clinic of internal diseases
Research Overview
- Evaluation of Safety, Efficacy, and Immunogenicity of Sequential Bepirovirsen and GSKVX000000008866 in Chronic Hepatitis B Patients on Nucleos(t)ide Analogue Therapy
- Evaluation of Long-term Treatment Response Durability in Chronic Hepatitis B Patients Post-Bepirovirsen Therapy with or without Nucleos(t)ide Analogue Therapy
- Efficacy and Safety of Bepirovirsen in Nucleos(t)ide Analogue-Treated Patients with Chronic Hepatitis B: A Phase 3 Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 39 of 89 partner sites.
Specializations
Hepatitis Research
This investigator specializes in advancing therapeutic approaches for chronic Hepatitis B (CHB), with particular emphasis on innovative treatment strategies for patients receiving ongoing care.
- Long-term treatment response monitoring
- Novel therapeutic combinations
- Nucleos(t)ide analogue therapy optimization
Their research extends to evaluating functional cure pathways and treatment durability in hepatitis patients.
Antiviral Therapeutics
The investigator focuses on developing targeted antiviral strategies, particularly examining the potential of antisense oligonucleotide treatments in hepatitis management.
- Sequential therapy approaches
- Immunotherapy integration
- Treatment response assessment
Their work encompasses evaluation of immune response patterns following various therapeutic interventions.
Clinical Safety Studies
The investigator conducts comprehensive research into the safety profiles of emerging hepatitis treatments, particularly in combination therapy contexts.
- Treatment durability assessment
- Long-term safety monitoring
- Therapeutic response evaluation
Their research includes systematic evaluation of treatment efficacy markers in chronic hepatitis patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.